Theravance Biopharma, Inc. — SC 13G/A Filings
60 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Theravance Biopharma, Inc. (TBPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Theravance Biopharma, Inc. has filed 60 SC 13G/A documents with the SEC since 2015. To view all SEC filings by Theravance Biopharma, Inc., see the full filings list.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001013594-24-000953 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-001259 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000692 | Nov 4, 2024 | — |
| SC 13G/A | — | 0000932471-24-000755 | Nov 4, 2024 | — |
| SC 13G/A | — | 0002012383-24-002295 | Oct 24, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-040632 | Sep 9, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-036630 | Aug 9, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-010814 | Jun 11, 2024 | — |
| SC 13G/A | — | 0001013594-24-000426 | May 3, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022091 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001086364-24-006892 | Feb 8, 2024 | — |
| SC 13G/A | NONE | 0001567619-23-006540 | Jul 10, 2023 | — |
| SC 13G/A | — | 0001013594-23-000205 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0000947871-23-000189 | Feb 14, 2023 | — |
| SC 13G/A | NONE | 0001567619-23-002555 | Feb 13, 2023 | — |
| SC 13G/A | — | 0001357550-23-000060 | Feb 10, 2023 | — |
| SC 13G/A | — | 0001306550-23-008612 | Feb 10, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-017096 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001013594-22-000208 | Feb 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0000899140-22-000327 | Feb 14, 2022 | — |
| SC 13G/A | NONE | 0001567619-22-003515 | Feb 11, 2022 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000947871-22-000215 | Feb 11, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018708 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000834237-22-006223 | Feb 3, 2022 | — |
| SC 13G/A | — | 0000315066-21-001806 | Oct 12, 2021 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-21-000394 | Oct 8, 2021 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-21-000349 | Apr 12, 2021 | — |
| SC 13G/A | NONE | 0001567619-21-003519 | Feb 12, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-019227 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-001278 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000834237-21-007507 | Feb 5, 2021 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-21-000044 | Feb 3, 2021 | — |
| SC 13G/A | — | 0000834237-20-010027 | Jul 10, 2020 | — |
| SC 13G/A | SC 13G/A | 0001193125-20-176545 | Jun 23, 2020 | — |
| SC 13G/A | — | 0000834237-20-009221 | Mar 9, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018589 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000315066-20-001235 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000834237-20-006945 | Feb 6, 2020 | — |
| SC 13G/A | AMENDMENT NO. 6 TO SCHEDULE 13G | 0001213900-19-022536 | Nov 8, 2019 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-19-002522 | Feb 14, 2019 | — |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-19-002526 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000315066-19-001362 | Feb 13, 2019 | — |
| SC 13G/A | — | 0000932471-19-005763 | Feb 12, 2019 | — |
| SC 13G/A | — | 0000215457-19-005828 | Feb 6, 2019 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-18-001706 | Feb 13, 2018 | — |
| SC 13G/A | NONE | 0001140361-18-007142 | Feb 13, 2018 | — |
| SC 13G/A | — | 0000315066-18-001639 | Feb 13, 2018 | — |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-18-001715 | Feb 13, 2018 | — |
| SC 13G/A | — | 0000932471-18-002756 | Feb 8, 2018 | — |
| SC 13G/A | — | 0000215457-18-004142 | Jan 30, 2018 | — |